New Century Healthcare Holding Co. Ltd. (1518) AI Stock Analysis

• Market Cap: HK$551.55M
• Dividend Yield: 3.15%
• Average Volume (3M): 79.42K
• Price to Earnings (P/E): 10.6
• Beta (1Y): 0.05
• Revenue Growth: -10.82%
• EPS Growth: -43.85%
• Country: HK
• Employees: 1,255
• Sector: Healthcare
• Sector Strength: 46
• Industry: Medical - Care Facilities
• EPS (TTM): 0.05
• Shares Outstanding: 490,025,000
• 10 Day Avg. Volume: 22,900
• 30 Day Avg. Volume: 79,416
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

New Century Healthcare's overall stock score is impacted by declining financial performance, particularly in revenue and net income. While the balance sheet remains stable, weak cash flows and market momentum indicators suggest caution. The stock is relatively undervalued with a reasonable dividend yield, but the risks associated with its current financial trajectory contribute to a moderate overall score.

New Century Healthcare Holding Co. Ltd. Business Overview & Revenue Model

Company Description

New Century Healthcare Holding Co. Ltd. (1518) is a prominent healthcare service provider in China, primarily focused on offering pediatric and obstetric services. The company operates a network of hospitals and clinics, providing a range of medical services including outpatient, inpatient, and health management services. It is dedicated to delivering high-quality healthcare services with a focus on family health, particularly in maternal and child care.

How the Company Makes Money

New Century Healthcare Holding Co. Ltd. generates revenue through its network of hospitals and clinics by providing a variety of healthcare services. The company earns income from outpatient and inpatient services, which include consultations, medical treatments, and surgeries for pediatric and obstetric care. Additionally, the company offers health management services, further contributing to its revenue streams. The company may also generate revenue through strategic partnerships with medical suppliers and insurance companies, enhancing its service offerings and patient reach. Key factors contributing to its earnings include the growing demand for specialized healthcare services in China, particularly in pediatric and maternal care, and the company's ability to maintain a strong reputation in delivering high-quality medical services.

New Century Healthcare Holding Co. Ltd. Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
933.07M	636.46M	632.57M	512.78M	729.37M
	Gross Profit
407.09M	202.14M	198.74M	135.76M	261.30M
	EBIT
171.81M	-20.28M	-25.41M	-46.04M	62.63M
	EBITDA
234.18M	-209.54M	41.78M	-218.17M	174.65M
	Net Income Common Stockholders
84.16M	-291.57M	-85.26M	-377.53M	4.49M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
304.31M	226.08M	223.84M	299.21M	410.25M
	Total Assets
944.39M	901.38M	1.27B	1.47B	1.88B
	Total Debt
206.07M	217.02M	280.24M	361.10M	356.40M
	Net Debt
-98.24M	-9.06M	56.40M	61.88M	7.28M
	Total Liabilities
492.63M	540.03M	586.66M	659.19M	643.14M
	Stockholders Equity
522.28M	438.26M	737.46M	838.63M	1.21B
Cash Flow		Free Cash Flow
148.21M	66.16M	9.10M	-18.73M	104.18M
	Operating Cash Flow
158.92M	76.28M	22.25M	-4.22M	126.79M
	Investing Cash Flow
-8.64M	-23.07M	-15.74M	47.82M	-50.99M
	Financing Cash Flow
-73.07M	-57.26M	-79.84M	-86.47M	-162.39M

New Century Healthcare Holding Co. Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1.20
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1518, the sentiment is Positive. The current price of 1.2 is above the 20-day moving average (MA) of 1.13, above the 50-day MA of 1.17, and above the 200-day MA of 0.99, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 65.59 is Neutral, neither overbought nor oversold. The STOCH value of 26.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1518.

New Century Healthcare Holding Co. Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3866	76 Outperform	HK$26.50B	5.05	11.99%	4.98%	4.33%	17.13%
1763	73 Outperform	HK$3.74B	8.47	8.40%	3.63%	12.41%	―
6098	68 Neutral	$23.50B	12.07	4.96%	0.36%	1.31%	379.84%
1518	59 Neutral	HK$551.55M	10.63	8.82%	3.15%	-10.82%	-43.85%
Sector *	52 Neutral	$5.15B	3.56	-42.52%	2.83%	14.56%	-0.53%
3869	48 Neutral	HK$939.72M	―	-10.78%	―	-0.95%	-128.35%

New Century Healthcare Holding Co. Ltd. Corporate Events

New Century Healthcare Announces 2025 Annual General Meeting Agenda

New Century Healthcare Holding Co. Ltd. has announced its upcoming annual general meeting scheduled for May 22, 2025, in Beijing. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, re-appointment of auditors, and approval of a final dividend of HK$0.0221 per share. The meeting will also consider granting the board a mandate to issue additional shares, which could impact the company’s capital structure and shareholder value.

New Century Healthcare Reports Revenue Decline Amidst Market Normalization

New Century Healthcare Holding Co. Ltd. reported a decline in revenue and profit for the year ended December 31, 2024, primarily due to a decrease in demand for pediatric internal medicine services as the market returned to normal levels following a surge in pediatric infections in 2023. Despite the financial downturn, the company announced a final dividend of HK$0.0221 per share, subject to shareholder approval, reflecting its commitment to returning value to its shareholders.

New Century Healthcare Announces Final Dividend for 2024

New Century Healthcare Holding Co. Ltd. has announced a final cash dividend of HKD 0.0221 per share for the financial year ending December 31, 2024. This decision reflects the company’s financial performance and commitment to returning value to its shareholders. The dividend will be paid on July 2, 2025, following shareholder approval on May 22, 2025. This announcement highlights the company’s stable financial position and its dedication to maintaining shareholder trust and satisfaction.

New Century Healthcare Announces Board Meeting for Annual Results

New Century Healthcare Holding Co. Ltd. has announced that its board of directors will meet on March 27, 2025, to approve the release of the company’s annual results for the year ending December 31, 2024. This meeting is significant as it will also address other business matters, potentially impacting the company’s strategic direction and stakeholder interests.

New Century Healthcare Issues Profit Warning Amid Decline in Pediatric Service Demand

New Century Healthcare Holding Co. Ltd. has issued a profit warning, anticipating a significant decrease in profit for the year ending December 31, 2024, compared to the previous year. The decline is attributed to a normalization of demand for pediatric internal medicine services following an exceptional surge in 2023 due to increased pediatric infections. This reduction in demand has led to decreased revenue and gross profit, impacting the company’s overall profitability.